Lentiviral gene transfer-mediated cone vision restoration in rpe65 knockout mice

Advances in Experimental Medicine and Biology

Volumn 613, Issue , 2008, Pages 89-95

  Bemelmans, Alexis Pierre ^a   Kostic, Corinne ^b   Cachafeiro, Maité ^b   Crippa, Sylvain V ^b   Wanner, Dana ^b   Tekaya, Meriem ^b   Wenzel, Andreas ^b   Arsenijevic, Yvan ^b  

^a HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; PROTEIN RPE654_DLNK ENDOGENOUS COMPOUND; UNCLASSIFIED DRUG; CARRIER PROTEIN; COMPLEMENTARY DNA; GNAT2 PROTEIN, MOUSE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RPE65 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CONE; VISUAL ACUITY; ANIMAL; ARTICLE; C57BL MOUSE; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; MOUSE MUTANT; PATHOLOGY; TRANSGENE; VISION;

MUS;

ANIMALS; CARRIER PROTEINS; CONES (RETINA); DNA, COMPLEMENTARY; EYE PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HETEROTRIMERIC GTP-BINDING PROTEINS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSGENES; VISION;

EID: 38949198775     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74904-4_9     Document Type: Conference Paper

References (24)

1. Acland, G. M., Aguirre, G. D., Bennett, J., et al., 2005, Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness, Mol Ther . 12: 1072-1082.
2. Acland, G. M., Aguirre, G. D., Ray, J., et al., 2001, Gene therapy restores vision in a canine model of childhood blindness, Nat Genet 28: 92-95.
3. Aguirre, G. D., Baldwin, V., Pearce-Kelling, S., et al., 1998, Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect, Mol Vis 4: 23.
4. Auricchio, A., Kobinger, G., Anand, V., et al., 2001, Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model, Hum Mol Genet 10: 3075-81.
5. Bainbridge, J. W., Tan, M. H. and Ali, R. R., 2006, Gene therapy progress and prospects: the eye, Gene Ther 13: 1191-97.
6. Bemelmans, A. P., Bonnel, S., Houhou, L., et al., 2005, Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter, J Gene Med 7: 1367-74.
7. Bemelmans, A. P., Kostic, C., Crippa, S. V., et al., 2006, Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis, PLoS Med 3: e347.
8. Gu, S. M., Thompson, D. A., Srikumari, C. R., et al., 1997, Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy, Nat Genet 17: 194-97.
9. Hanein, S., Perrault, I., Gerber, S., et al., 2004, Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis, Hum Mutat 23: 306-17.
10. Jacobson, S. G., Boye, S. L., Aleman, T. S., et al., 2006, Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis, Hum Gene Ther 17: 845-58.
11. Jin, M., Li, S., Moghrabi, W. N., et al., 2005, Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium, Cell 122: 449-59.
12. Kostic, C., Chiodini, F., Salmon, P., et al., 2003, Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina, Gene Ther 10: 818-21.
13. Le Meur, G., Stieger, K., Smith, A. J., et al., 2007, Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium, Gene Ther 14: 292-303.
14. Miyoshi, H., Takahashi, M., Gage, F. H. and Verma, I. M., 1997, Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector, Proc Natl Acad Sci U S A 94: 10319-23.
15. Moiseyev, G., Chen, Y., Takahashi, Y., et al., 2005, RPE65 is the isomerohydrolase in the retinoid visual cycle, Proc Natl Acad Sci U S A 102: 12413-8.
16. Narfström, K., Katz, M. L., Bragadottir, R., et al., 2003, Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog, Invest Ophthalmol Vis Sci 44: 1663-72.
17. Narfström, K., Vaegan, Katz, M., et al., 2005, Assessment of structure and function Over a 3-year period after gene transfer in RPE65-/- dogs, Doc Ophthalmol 111: 39-48.
18. Redmond, T. M., Yu, S., Lee, E., et al., 1998, Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle, Nat Genet 20: 344-51.
19. Rohrer, B., Lohr, H. R., Humphries, P., et al., 2005, Cone opsin mislocalization in Rpe65-/- Mice: A defect that can be corrected by 11-cis retinal, Invest Ophthalmol Vis Sci 46: 3876-82.
20. Saari, J. C., 2000, Biochemistry of visual pigment regeneration: the Friedenwald lecture, Invest Ophthalmol Vis Sci 41: 337-48.
21. Schmucker, C., Seeliger, M., Humphries, P., et al., 2005, Grating acuity at different luminances in wild-type mice and in mice lacking rod or cone function, Invest Ophthalmol Vis Sci 46: 398-407.
22. Seeliger, M. W., Grimm, C., Stahlberg, F., et al., 2001, New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis, Nat Genet 29: 70-74.
23. Yanez-Munoz, R. J., Balaggan, K. S., Macneil, A., et al., 2006, Effective gene therapy with nonintegrating lentiviral vectors, Nat Med 12: 348-53.
24. Znoiko, S. L., Rohrer, B., Lu, K., et al., 2005, Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65-/- mouse at early ages, Invest Ophthalmol Vis Sci 46: 1473-79.